Michael Coffee

USPTO Granted Patents = 10 (Patent Applications = 18)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 4.6

ph-index = 7

Forward Citations = 132(Granted Patents)

Location History:

Greensboro, NC (US) (2011 - 2013)
Tiburon, CA (US) (2014 - 2021)

Company Filing History:

Adamas Pharmaceuticals, Inc.

patents

Years Active: 2011-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11197835 - Method of administering amantadine prior to a sleep period (2021-12-14),

2. 9877933 - Method of administering amantadine prior to a sleep period (2018-01-30),

3. 9867793 - Method of administering amantadine prior to a sleep period (2018-01-16),

4. 9867792 - Method of administering amantadine prior to a sleep period (2018-01-16),

5. 9867791 - Method of administering amantadine prior to a sleep period (2018-01-16),

6. 8741343 - Method of administering amantadine prior to a sleep period (2014-06-03),

7. 8512787 - Process for manufacturing chewable dosage forms for drug delivery and products thereof (2013-08-20),

8. 8293265 - Process for manufacturing chewable dosage forms for drug delivery and products thereof (2012-10-23),

9. 8114455 - Process for manufacturing chewable dosage forms for drug delivery and products thereof (2012-02-14),

10. 7955632 - Process for manufacturing chewable dosage forms for drug delivery and products thereof (2011-06-07),

Title: Innovations by Michael Coffee: A Pioneer in Amantadine Administration

Introduction

Michael Coffee is an accomplished inventor based in Tiburon, CA, with a remarkable portfolio of 10 patents. His work primarily focuses on the administration of amantadine, a medication used to treat various conditions, including Parkinson's disease and influenza. Coffee's innovative approaches aim to enhance patient care and improve treatment outcomes.

Latest Patents

Among his latest patents, Coffee has developed methods for administering amantadine prior to a sleep period. These methods are designed to reduce sleep disturbances in patients undergoing treatment with amantadine. Additionally, he has created compositions of extended-release amantadine that are suitable for nighttime administration, ensuring that patients receive optimal therapeutic benefits while minimizing side effects.

Career Highlights

Throughout his career, Michael Coffee has made significant contributions to the pharmaceutical industry. He has worked with notable companies such as Adamas Pharmaceuticals and Bayer B.V., where he has applied his expertise in drug formulation and patient care. His innovative solutions have garnered attention and respect within the medical community.

Collaborations

Some of Coffee's notable coworkers include Gregory T. Went and Gayatri Sathyan. Their collaborative efforts have further advanced the research and development of amantadine administration methods.

Conclusion

Michael Coffee's contributions to the field of pharmaceutical innovation, particularly in the administration of amantadine, highlight his dedication to improving patient outcomes. His patents and collaborations reflect a commitment to advancing medical science and enhancing the quality of life for patients.

This text is generated by artificial intelligence and may not be accurate.